A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EPO / European Patent Office

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EPO  (>> Co-occurring Abbreviation)
Long Form:   European Patent Office
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association. ---
2019 Evolution of World and Brazilian Markets for Enzymes Produced by Solid-State Fermentation: A Patent Analysis. SSF
2019 Medical device patents-a review of contemporary global trends with an Irish comparison. USPTO
2019 Nucleic Acid Therapeutics in Huntington's Disease. ASOs, HD, RNAi, USPTO
2019 Prospective Study of Microbial Colorants Under Focus of Patent Documents. ---
2018 Converting Enzymes into Tools of Industrial Importance. USPTO
2018 Design and development of a manual pump for bolus enteral nutrition. EN
2018 Dignity again. TLM
2018 Examiner trust in applicants to the European Patent Office: country specificities. ---
10  2017 Disambiguation of patent inventors and assignees using high-resolution geolocation data. PCT
11  2017 Patenting medical diagnosis methods in Europe: Stanford University and time-lapse microscopy. ESHRE
12  2017 Time-lapse microscopy patent upheld in Europe: response to Pearce. ---
13  2017 [Dosing regimens in second medical use patents]. ---
14  2016 Searching bioremediation patents through Cooperative Patent Classification (CPC). CPC, ECLA, IPC, USPTO
15  2016 TECHNOLOGICAL INFORMATION REGARDING PREBIOTICS AND PROBIOTICS NUTRITION VERSUS THE PATENT REGISTERS: WHAT IS NEW? ---
16  2015 Interfacing of Science, Medicine and Law: The Stem Cell Patent Controversy in the United States and the European Union. USPTO
17  2015 Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis. ---
18  2014 Is the European Patent Office's approach to assessing obviousness of antibody inventions consistent? ---
19  2014 Patentability of genes: a European Union perspective. ---
20  2014 Trends in genetic patent applications: the commercialization of academic intellectual property. EP, IPC, PCT
21  2013 Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science. EU, hESC
22  2013 Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells. ---
23  2012 The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity. ---
24  2011 Mining chemical information from open patents. ---
25  2011 Patent prosecution at the European Patent Office: what is new for life sciences applicants? EPC
26  2009 Nano Mapper: an Internet knowledge mapping system for nanotechnology development. JPO, NSF, USPTO
27  2007 The university-promoted patent at the crossroads of the research results and immediate industrial use. ---
28  2006 Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13. ---
29  2005 The immoral gene: does it really exist? EPC
30  2004 [The supply of breast/ovarian cancer genetic susceptibility tests in France]. ---
31  2003 Patent protection for structural genomics-related inventions. JPO, USPTO
32  2003 Patenting of genome research results. JPTO, USPTO
33  2003 The EMBL Nucleotide Sequence Database: major new developments. EBI, SRS
34  2002 The EMBL Nucleotide Sequence Database. EBI, SRS
35  2001 The EMBL nucleotide sequence database. DDBJ, EBI, SRS
36  2000 An analysis of moral issues affecting patenting inventions in the life sciences: a European perspective. ---
37  2000 The EMBL nucleotide sequence database. DDBJ, EBI, EMBL, SRS
38  1999 The EMBL Nucleotide Sequence Database. EBI, SRS